Kang Nuoya Biomedical Technology (Chengdu) Co., Ltd.
康诺亚
Kang Nuoya Biomedical Technology (Chengdu) Co., Ltd.
Biotech/Healthcare
Keymed Biosciences, founded on April 23, 2018, is a biotechnology company with multiple clinical-stage assets, each of which is among the top three domestically developed drugs with the same target or of the same class to have obtained clinical trial application approvals in China or the United…
Latest round: IPO (2021)
Source: ChinaBulls — chinabulls.com
Last updated 2021-07-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.